The Zacks Analyst Blog Highlights:

This story originally appeared on Zacks

For Immediate Release

Chicago, IL – February 3, 2022 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Chevron Corp. CVX, HSBC Holdings plc HSBC, and Anthem, Inc. ANTM.

– Zacks

Here are highlights from Wednesday’s Analyst Blog:

Top Research Reports for Chevron, HSBC and Anthem

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Chevron Corp. (CVX), HSBC Holdings plc (HSBC), and Anthem, Inc. (ANTM). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of Chevron have underperformed the Zacks Integrated Oil industry over the past year (+59.5% vs. +69.6%), however, things seem to be improving. The Zacks analyst believes that Chevron’s acquisition of Noble Energy has expanded its presence in the DJ Basin as well as the Permian Basin, along with the addition of cash generating offshore assets in Israel.

Based on a slew of other tailwinds, CVX remains poised for capital appreciation in the quarters ahead. It boasts a project pipeline that is among the best in the industry, thanks to its premier position in the lucrative Permian. Chevron, however, can be exposed to volatility in commodity prices. It has also witnessed its debt-to-equity go up from 18.6% at the start of 2020 to 27.3% as of Sep 30.

(You can read the full research report on Chevron here >>>)

HSBC shares have gained +34.1% over the past six months against the Zacks Foreign Banks industry’s rise of +8.9%. The Zacks analyst believes that HSBC’s robust capital position, brand value and a widespread network remain as the major tailwinds. Its restructuring initiatives are also impressive.

HSBC’s deal to buy AXA Singapore insurance assets and L&T Investment Management Limited will likely help expand business in Asia. Initiatives to improve market share in the U.K. and China will likely support its financials. These efforts, however, might lead to a rise in costs, thereby weighing on margins. Lower interest rates and weak loan demand are other major concerns for HSBC.

(You can read the full research report on HSBC here >>>)

Shares of Anthem have gained +3.7% in the last three months against the Zacks HMO industry’s gain of +1.9%. The Zacks analyst believes that acquisitions and collaborations have helped Anthem boost its Medicare Advantage as well as strengthen its business portfolio.

Well-performing Medicare and Medicaid businesses coupled with several contract wins are expected to drive Anthem’s membership. Solid earnings guidance for 2022 is impressive. It witnessed a rise in usage of its virtual care services. Escalating costs and a weak balance sheet with a massive debt burden of $21.1B have been weighing on it margins, though.

(You can read the full research report on Anthem here >>>)

Other noteworthy reports we are featuring today include  Citigroup Inc. (C) and Target Corp. (TGT).

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +25.3% per year.

These 7 were selected because of their superior potential for immediate breakout. 

See these time-sensitive tickers now >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339                                                                                 

pPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Just Released: Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?

From inception in 2012 through 2021, the Zacks Top 10 Stocks portfolios gained an impressive +1,001.2% versus the S&P 500’s +348.7%. Now our Director of Research has combed through 4,000 companies covered by the Zacks Rank and has handpicked the best 10 tickers to buy and hold. Don’t miss your chance to get in…because the sooner you do, the more upside you stand to grab.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Chevron Corporation (CVX): Free Stock Analysis Report
HSBC Holdings plc (HSBC): Free Stock Analysis Report
Anthem, Inc. (ANTM): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research


Hippo Sighting Report

Help us out, we really appreciate it.

Help contribute to our research, and let us know if you have seen similar situations that we may have missed. Our team will review the details you provide and add to our main list once we verify the information.

stay informed

Subscribe and get the updated Hippo List.

Get notified when we release our updated lists by email.

Make a Donation

Thank you for subscribing!

We will send you an email to confirm your details.  Welcome aboard!

Thanks for sending us your report.

We will review your information, and publish in on our list once we validate the details.